TSX lower after index logs fresh record closing high
LONDON - Advanced Medical Solutions Group plc (AIM:AMS), a specialist in tissue-healing technologies, has applied to the London Stock Exchange for a block listing of 10.4 million ordinary shares to be admitted to trading on AIM, according to a press release statement.
The application, announced Wednesday, covers new ordinary shares of 5 pence each that will be issued when employees exercise share options under the company’s existing schemes. The company expects admission to become effective on September 15, 2025.
The block listing application includes 2 million shares for the Employee Share Purchase Plan, 200,000 shares for the Company Share Option Plan, 200,000 shares for the Unapproved Executive Share Option Scheme, 4 million shares for the Long-Term Incentive Plan, and 4 million shares for the Group Share Option Plan.
AMS specified that when issued, the new ordinary shares will be credited as fully paid and will rank equally with existing ordinary shares of the company.
The company noted that following the admission of these ordinary shares, there will be no change to its current issued share capital, which consists of 219,330,534 ordinary shares with voting rights.
Advanced Medical Solutions, based in Winsford, UK, develops and manufactures tissue-healing technology products including tissue adhesives, sutures, haemostats, and wound care dressings. The company markets its products under various brands and has operations across multiple countries.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.